Role of glycosaminoglycans in pathogenesis of atherosclerosis
Sukmans'kyĭ OI, Drohomyrets'ka MS, Den'ha OV, Sukmans'kyĭ IO
- Odesa State Agrarian University, Ukraine
-
- P.L.Shupik National Medical Academy of Post-graduateEducation, Kyiv, Ukraine
- Institute of Stomatology AMS of Ukraine, Odesa, Ukraine
DOI: https://doi.org/10.15407/fz56.05.106
![](/images/cite.png)
Abstract
In this review we summarize the role of glycosaminoglycans and proteoglycans in pathogenesis of atherosclerosis and possibilities for correction of lesions of atherosclerotic vessels via influence on their metabolism.
Keywords:
glycosaminoglycans, proteoglycans, athero-sclerosis, arterial wall
References
Berezovsky V.Ya., Litovka IG, Kostyuchenko OS Physiological bone regeneration under dosage normobaric hypoxia . Fiziol zh. . 2007. 57, N 6. P.40-45.
Boiko E. P., Kaneva A.M. Apoproten E i ego znachenie v klinicheskoi fiziologii. Uspehi fiziol. nauk. 2009. 40,N 1. S.3-15.
Gorohivskii V.N., Podorozhnaya R.P., Sukmanskii O.I., Den'ga O.V., Knava O.E., Makarenko O.A. Narusheniya sinteza glikozaminoglikanov pri eksperimental'nom flyuoroze i puti ih korrektsii. . Ros. stomatol. zhurn. 2008, N 1. S.11-13.
Dil'man V.M. Starenie, klimaks i rak. L., 1968. 130 s.
Drogomiretskaya M.S., Sukmanskii O.I., Den'ga O.V., Makarenko O.A., Podorozhnaya R.P., Knava O.E. Obmen glikozaminoglikanov (GAG) v tkanyah polosti rta i nekotorih vnutrennih organah pri eksperimental'nom ateroskleroze i ego lechenii na fone ortodonticheskogo vmeshatel'stva.Visn. stomatologii. 2007. N 3. C.11-16.
Drogomiretskaya M.S., Sukmanskii O.I., Den'ga O.V. Podorozhnaya R.P., Knava O.E. Obmen serosoderzhashchih soedinenii pri eksperimental'nom ateroskleroze. YaP Mizhnar. nauk. konf. "Gomeostaz, fiziologiya, patologiya, farmakologiya i klinika": Tezi dop., Odesa, 2007. S.39-40.
Ievdokimova N.Yu. Gialuronova kislota, retseptor CD44 ta ihnya rol' v uskladnennyah tsukrovogo diabetu.Ukr.biohim. zhurn. 2008. 80, N 5. S.5-44.
Krasnikova T.L., Aref'eva T.P., Kuhtina N.B. Hemokini, retseptori hemokinov i aterogenez. Uspehi sovrem. biologii. 2003. 123,N 5. S.506-514.
Nagornev V.A., Voskan'yants A.N. Aterogenez kak immuno-vospalitel'nii protsess. Vesti. RAMN. 2004. N 7. S.3-11.
Sidorenko B.A., Zaikina N.V., Preobrazhenskii D.V. Enoksaparin i drugie nizkomolekulyarnie geparini v kardiologii.Kardiologiya. 1998. N 10. S.82-90.
Sidorenko B.A., Preobrazhenskii D.V. Nizkomolekulyarnie geparini: vozmozhnost' primeneniya. Kardiologiya. 1995. N 10. S.86-91.
Stoika R.S., Fil'chenkov A.A., Zalesskii V.N. Tsitokini i kletki-misheni v regulyatornoi sisteme aterogeneza.Uspehi sovrem.biologii. 2003. 123,N 1. S.82-97.
Sudans'kii O.I. Tsitokini nova sistema bioregu-lyatoriv .Visn. stomatologii. 2005. N 3. S.69-74.
Sukmans'kii O.I., Gorohivs'kii V.N. Glikoza-minoglikani (GAG) i kistkova tkanina.Visn. stomatologii. 2009. N 3. S.113-118.
Tsurko V.V., Leonenko I.V., Egorov I.V., Krasnosel'skii M.Ya. Rol' mediatornih mehanizmov v immunopatogeneze vospaleniya pri serdechnososudistih zabolevaniyah i osteoporoze.Terap. arhiv. 2009. 81, N 6. S. 92-96.
Allain F., Vanpouille C., Carpentier M. Slomianny M.C., Durieux S., Spik G. Interaction with glycosami-noglycans is required for cyclophilin B to trigger integrin-mediated adhesion of peripheral blood T-lymphocytes to extracellular matrix. Proc. Nat. Acad. Sci. USA. 2002. 99, N 5. P.2714-2719.
CrossRef
PubMed PubMedCentral
Bot P.T., Hoefer I.E., Piek J.J., Pasterkamp G. Hyaluronic acid: targeting immune modulatory components of the extracellur matrix in atherosclero-sis.Curr. Med. Chem. 2008. 5. N 8. P.786-791.
CrossRef
PubMed
Chai S., Chai Q., Danielsen C.C., Hjorth P., Nyengaard J.R., Ledet T., Yamaguchi Y., Rasmussen L.M., Wogensen L. Overexpression of hyaluronan in the tunica media promotes the development of atherosclero-sis.Circulat. Res. 2005. 96. N 5. P.583-591.
CrossRef
PubMed
Dadlani H., Ballinger M.L., Osman N., Getachew R., Little P.J. Smad and p38 MAP kinase-mediated signaling of proteoglycan synthesis in vascular smooth muscle.J. Biol. Chem. 2008. 283. N 12. P.7844-7852.
CrossRef
PubMed
Deepa P .R., Varalakshmi P. Atheroprotective effect of exogenous heparin-derivative treatment on the aortic disturbances and lipoprotein oxidation in hypercho-lesterolemic diet fed rats.Clin. Chim. Acta. 2005. 355,N 1-2. P.l19-130.
CrossRef
PubMed
Deepa PR., Varalakshmi P. Favourable modulation of the inflammatory changes in hypercholesterolemic athero-genesis by a low-molecular-weight heparin derivative. Int. J. Cardiol. 2006. 106, N 3. P.338-347.
CrossRef
PubMed
Delmolino L.M., Stearns N.A, Castellot Jr. J.J. COP-l, a member of the CCN family, is a heparin-induced growth arrest specific gene in vascular smooth muscle cells.J. Cell Physiol. 200I. 188, N 1. P.45-55.
CrossRef
PubMed
De Lorenzo F., Dotsenko O., Kakkar YY. Low molecular weight heparins in cardiovascular medicine. Minerva Cardioangiol. 2005. 53, N 6. P.585-603.
Duan Y, Paka L., Pillarisetti S. Distinct effects of glucose and glucosamine on vascular endothelial and smooth muscle cells: evidence for a protective role for glucosamine in atherosclerosis.Cardiovasc. Diabetol. 2005. 4. P. 16.
CrossRef
PubMed PubMedCentral
Elhadj S., Mousa S.A., Forsten-Williams K. Chronic pulsatile shear stress impact synthesis of proteoglycans by endothelial cells effect on platelet aggregation and coagulationJ. J. Cell Biochem. 2002. 86, N 2. P.239-250.
CrossRef
PubMed
Fischer J. W., Schrnr K. Regulation of hyaluronan synthesis by vasodilatory prostaglandins. Implications for atherosclerosis.Throm. Haemost. 2007. 98, N 2. P.287-295.
CrossRef
PubMed
Gounffic Y, Guilluy C, Guirin P., Patra P., Pacaud P., Loirand G. Hyaluronan induces vascular smooth muscle cell migration through RHAMM-mediated PI3K-de-pendent Rac activation.Cardiovasc. Res. 2006. 72, N 2. P.339-348.
CrossRef
PubMed
Hamati H.F., Britton E.L., Carey D.J. Inhibition of proteoglycan synthesis alters extracellular matrix deposition, proliferation, and cytoskeletal organization of rat aortic smooth muscle cells in culture.J. Cell Biol. 1989. 108,N 6. P.2495-2505.
CrossRef
PubMed PubMedCentral
Herrero-Beaumont G., Marcos M.E., S6nchez-Pernaute O., Granados R., Ortega L., Montell E., Vergfis J., Egido J. Effect of chondroitin sulphate in a rabbit model of atherosclerosis aggravated by chronic arthritis.Brit. J. Pharmacol. 2008. 154, N 4. P.843-851.
CrossRef
PubMed PubMedCentral
Iwasaki S., Minamisawa S., Yokoyama U., Akaike T., Quan H., Nagashima Y, Nishimaki S., Ishikawa Y Interleukin-15 inhibits smooth muscle cell proliferation and hyaluronan production in rat ductus arteriosus. . Pediatr. Res. 2007. 62, N 4. P.392-398.
CrossRef
PubMed
Kumar v., Cotran R.S., Robbins S.L. Robbins Basic Pathology. 7th ed. Philadelphia, London, Toronto etc.: W.B. Saunders Company, 2003. 873 p.
Lake A.C., Bialik A., Walsh K., Castellot J.J. CCN5 is a growth arrest-specific gene that regulates smooth muscle cell proliferation and motility. Amer. J. Pathol. 2003. 162, N 1. P.219-231.
CrossRef
Lee M., Sommerhoff C.P., von Eckardstein A., Zettl F., Fritz H., Kovanen P.T. Mast cell tryptase degrades HDL and blocks its function as an acceptor of cellular cholesterol. Arterioscler. Thromb. Vasc. Biol. 2002. 22,N 12. P.2086-2091.
CrossRef
PubMed
Libeu C.P, Lund-Katz S., Phillips M.C., Wehrli S., Hernaiz M.J., Capila I., Linhardt R.J., Raffai R.L., Newhouse YM. New insights into the heparan sulfate proteoglycan-binding activity of apolipoprotein E.J. Biol. Chem. 2001. 276, N 42. P.39138-39144.
CrossRef
PubMed
Little. P.J., Ballinger M.L., Burch M.L., Osman N. Biosynthesis of natural and hyperelongated chondroitin sulfate glycoaminoglycans: new insights into an elusive process. Open Biochem. J. 2008. 2. P.135-142.
CrossRef
PubMed PubMedCentral
McDonald T.O., Gerrity R.G., Jen C, Chen H.J., Wark K., Wight T.N., Chait A., O'Brien K.D. Diabetes and arterial extracellular matrix changes in a porcine model of atherosclerosis. J. Histochem. Cytochem. 2007. 55, N 11. P.1149-1157.
CrossRef
PubMed PubMedCentral
Mahley R.W., Huang Y. Atherogenic remnant lipoproteins: role for proteoglycans in trapping, transferring, and internalizing.J. Clin. Invest. 2007. 117, N 1. P.94-98, 153-174.
CrossRef
PubMed PubMedCentral
Marks D.B. Biochemistry. 2nd ed. Philadelphia, Baltimore, Hong Kong, London etc.: Harwal Publishing, 1994. 337 p.
Mine S., Okada Y, Kawahara C, Tabata T., Tanaka Y Serum hyaluronan concentration as a marker of angi-opathy in patients with diabetes mellitus. Endocr. J. 2006. 53,N 6. P.761-766.
CrossRef
PubMed
Mishra-Gorur K., Delmolino L.M., Castellot Jr. J.J. Biological function of heparan sulfate and heparan sulfate proteoglycans.Trends Glycosci. Glycotechnol. 1998. l0. P.l93-210.
CrossRef
Nieuwdorp M., Holleman F., de Groot E., Vink H., Gort J., Kontush A., Chapman M.J., Hutten B.A. Perturbation of hyaluronan metabolism predisposes patients with type 1 diabetes mellitus to atherosclerosis. . Diabetologia. 2007. 50, N 6. P.I288-1293.
CrossRef
PubMed PubMedCentral
Nieuwdorp M., Meuwese M.C., Mooij H.L. van Lie-shout M.H., Hayden A., Levi M., Meiers J.C., Ince C, Kastelein J.J. Tumor necrosis factor-alpha inhibition protects against endotoxin-induced endothelial glycocalyx perturbation.Atherosclerosis. 2009. 202,N 1. P.296-303.
CrossRef
PubMed
Nishimura M., Ookawara T., Eguchi H., Fujiwara N., Yoshihara D., Yasuda D., Mimura O., Suzuki K. Inhibition of gene expression of heparin binding epidermal growth factor-like growth factor by extracellular superoxide dismutase in rat aortic smooth muscle cells. Free Radic. Res. 2006. 40, N 6. P.589-595.
CrossRef
PubMed
Potter D.R., Damiano E.R. The hydrodynamically relevant endothelial cell glycocalyx observed in vivo is absent in vitro. Circulat. Res. 2008. 102, N 7. P.747-748.
CrossRef
PubMed
Qui G., Hill J.S. Endothelial lipase promotes apolipoprotein AI-mediated cholesterol efflux in THP-1 macrophages.Arterioscler. Thromb. Vasc. Biol. 2009. 29,N 1. P.84-91.
CrossRef
PubMed
Ranjbaran H., Wang U., Manes T.D., Yakimov A.O., Akhtar S., Kluger M.S., Pober J.S., Tellides G. Heparin displaces interferon-gamma-inducible chemokines (IP-I0, I-TAC, and Mig) sequestered in the vasculature and inhibits the transendothelial migration and arterial recruitment of T cells.Circulation. 2006. 114,N 12. P.1293-1300.
CrossRef
PubMed
Ross. R. Atherosclerosis an inflammatory disease. N. Engl. J. Med. 1999. 340. P.115-126.
CrossRef
PubMed
Sakr S.W., Potter-Perigo S., Kinsella M.G., Johnson P.Y, Braun K.R., Goueffic Y, Rosenfeld M.E., Wight T.N. Hyaluronan accumulation is elevated in cultures of low density lipoprotein receptor-deficient cells and is altered by manipulation of cell cholesterol content. J. Biol. Chem. 2008. 283, N 52. P.36195-36204.
CrossRef
PubMed PubMedCentral
Seike M., Ikeda M., Matsumoto M., Hamada R., Takeya M., Kodama H. Hyaluronan forms complexes with low density lipoprotein while also inducing foam cell infiltration in the dermis. J. Dermatol. Sci. 2006. 41,N 3. P.197-204.
CrossRef
PubMed
Slevin M., Krupinski J., Gaffney J., Matou S., West D., Delisser H., Savani R.C, Kumar S. Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways. Matrix Biol. 2007. 26, N l. P.58-68.
CrossRef
PubMed
Stoll G., Bendszus M. Inflammation and atherosclerosis: novel insights into plaque formation and destabi-lzation.Stroke. 2006. 37, N 7. P.1923-1932.
CrossRef
PubMed
Tabata T., Mine S., Okada Y, Tanaka Y Low molecular weight hyaluronan increases the uptaking of oxidized LDL into monocytes. Endocr. J. 2007. 54, N 5. P.685-693.
CrossRef
PubMed
Tasaki H., Yamashita K., Tsutsui M., Kamezaki F., Kubara T., Tanaka S., Sasaguri Y, Adachi T., Nakashima Y Heparin-released extracellular superoxide dismutase is reduced in patients with coronary artery atherosclerosis. Atherosclerosis. 2006. 187, N 1. P.131-138.
CrossRef
PubMed
Theocharis A.D., Tsolakis I., Tzanakakis G.N., Kara-manos N.K. Chondroitin sulfate as a key molecule in the development of atherosclerosis and cancer progression. Adv. Pharmacol. 2006. 53. P.281-295.
CrossRef
Tollefsen D.M. Heparin cofactor II modulates the response to vascular injury. Arterioscler. Thromb. Vasc. Biol. 2007. 27, N 3. P.454-460.
CrossRef
PubMed
Tovar A.M., Pecly I.M., Rangel E.P., Melo-Filho N.M., Mourro P.A., Leite M. Jr. Experimentally induced metabolic acidosis in rabbits modulates the interaction of aortic glycosaminoglycan with plasma low-density lipoprotein an interesting observation about the association of acidosis and atherosclerosis. Atherosclerosis. 2007. 192, N 1. P.33-39.
CrossRef
PubMed
Vicente C.P., He L., Tollefsen D.M. Accelerated athero-genesis and neointima formation in heparin cofactor II deficient mice.Blood. 2007. 110, N 13. P.4261-4267.
CrossRef
PubMed PubMedCentral
Vigetti D., Viola M., Karousou E., Rizzi M., Moretto P., Genasetti A., Clerici M., Hascall V.C., De Luca G., Passi A. Hyaluronan-CD44-ERKl. 2 regulate human aortic smooth muscle cell motility during aging.J. Biol. Chem. 2008. 283, N 7. P.4448-4458.
CrossRef
PubMed
Wong K.S., Chen C, Ng P.W., Tsoi T.H., Li H.L., Fong W.C. Low-molecular-weight heparin compared with aspirin for the treatment of acute ischaemic stroke in Asian patients with large artery occlusive disease: a randomized study.Lancet Neurol. 2007. 6, N 5. P.407-413.
CrossRef
Yao Y, Rabodzey A., Dewey C.F. Jr. Glycocalyx modulates the motility and proliferative response of vascular endothelium to f1uid shear stress. Amer. J. Physiol, Heart Circ.Physiol. 2007. 293. N 2. P.H1023-1030.
CrossRef
PubMed
Zhao L., Lee E., Zukas A.M., Middleton M.K., Kinder M., Acharya P.S., Hall J.A., Rader D.J., Puri E. CD44 expressed on both bone marrow-derived and non-bone marrow-derived cells promotes atherogenesis in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2008. 28. N 7. P.1283-1289.
CrossRef
PubMed
|